Louis-Patrick Haraoui

Professor Haraoui is an anthropologist, medical microbiologist and infectious disease specialist. His research projects, combining tools from molecular microbiology, history and ethnography, focus on: antimicrobial resistance (AMR); collective microbiomes.

Pr. Haraoui is a FRQS Junior 1 Clinical Research Scholar. He is nominated principal investigator (NPI) on a project on the biohistory of antibiotic-resistant Acinetobacter baumannii in the Middle East (New Frontiers in Research Fund – Exploration Stream). He was NPI on a Canadian Institutes of Health Research catalyst grant on the Global Governance of AMR in Conflicts.

Pr. Haraoui accepts to receive applications for graduate and post-doctoral students.

Interests : Microbiology, Anthropology & Resistance to antibiotics

Researcher’s projects

Reconstructing the social and environmental forces driving the evolution of multidrug-resistant Acinetobacter baumannii
New Frontiers in Research Fund 2020-2023
Principal Investigator : Louis-Patrick Haraoui
Co-investigator : Hannah Landecker
Co-applicant : Antoine Abou-Fayad, Ghassan Matar, Michael Mulvey, Omar Dewachi, Paul Higgins, Sébastien Rodrigue, Vincent Burrus, Vinh-Kim Nguyen
Telemicrobiology in Humanitarian Crises
Grand Challenges Canada 2019-2021
Principal Investigator : Humam Dawood
Collaborators : Louis-Patrick Haraoui, Aula Abbara, Daniel Rhoads, Diaa Adeen Al-Zamel, Konstantinos Antypas, Liron Pantanowitz, Munzer Al-Khalil, Nabil Karah et Wael Al-Emin
Building an Interdisciplinary Research Centre on the Global Governance of Antimicrobial Resistance in Conflicts (G2-ARC)
Canadian Institutes of Health Research – 2018-2019
Principal investigator : Louis-Patrick Haraoui

Selected publications

Bastos ML, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC, Lan Z, Law S, MacLean E, Trajman A, Menzies D, Benedetti A, Ahmad Khan F. 2020. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. British Medical Journal
Bazzi W, Abou Fayad AG, Nasser A, Haraoui LP, Nguyen VK, Dewachi O, Abu Sitta GS, Landecker H, Abbara A, Karah N, Knapp CW, McEvoy M, Zaman MH, Higgins PG, Matar GM. 2020. Heavy Metal Toxicity in Armed Conflicts Potentiates AMR in A. baumannii  by Selecting for Antibiotic and Heavy Metal Co-resistance Mechanisms. Frontiers in Microbiology
Sebastiani G, Saeed S, Lebouche B, de Pokomandy A, Szabo J, Haraoui LP, Routy JP, Wong P, Deschênes M, Ghali P, Klein M. 2020. Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients. AIDS 34 (2): 237-44.
Haraoui LP, Sparrow A, Sullivan R, Burci GL, Dewachi O, Abu-Sittah G, Nguyen VK. 2019. Armed conflicts and antimicrobial resistance: A deadly convergence. AMR Control 2019-20: 69-73. http://resistancecontrol.info/wp-content/uploads/2019/05/Haraoui.pdf
Semret M, Haraoui LP. 2019. Antimicrobial resistance in the tropics. Infect Dis Clin North Am 33 (1): 231-45.
Haraoui LP, Valiquette L, Laupland K. 2018. Antimicrobial resistance in conflicts. JAMMI 3 (3): 119-22.
Mulvey MR, Haraoui LP, Longtin Y. 2016. Multiple Variants of Klebsiella pneumoniae Producing Carbapenemase in One Patient. N Engl J Med 375(24): 2408-2410.
Haraoui LP, Lévesque S, Lefebvre B, Blanchette R, Tomkinson M, Mataseje L, Mulvey MR, Miller MA. 2013. Polyclonal Outbreak of KPC-3-Producing Enterobacter cloacae at a Single Hospital in Montréal. Québec, Canada. J Clin Microbiol 51(7): 2406-8.

Researcher’s projects

Selected publications

Links to publications